GLP-1 is an incretin hormone produced in the gut that enhances insulin secretion in response to food intake while suppressing glucagon, slowing gastric emptying, and reducing appetite ( [1] ) ( [2] )
The GLP-1 Support Menu was developed in partnership with a registered dietician and offers five smoothies with weight loss patients in mind October 30, 2024 Smoothie King this week became the first quick-service chain to offer a GLP-1 support menu specifically designed for customers on weight loss drugs like Ozempic
Rashes can appear shortly after starting semaglutide or after a few weeks of use
Weight loss results vary significantly by specific medication and dose: Semaglutide 2.4 mg (Wegovy): Clinical trials (STEP program) showed average weight reductions of 1517% at 68 weeks Tirzepatide (Zepbound): SURMOUNT trials demonstrated weight reductions of 1522% at 72 weeks, with results varying between populations with and without diabetes Liraglutide 3 mg (Saxenda): Typically produces 510% weight loss over 56 weeks The rate of weight loss is not linear
is supported, in part, by a Banting and Best Diabetes CentreNovo Nordisk Chair in Incretin Biology, a Sinai HealthNovo Nordisk Foundation Fund in Regulatory Peptides, CIHR grants 154321 and 19204 and Diabetes Canada-Canadian Cancer Society grant (OG-3- 24-5819-DD)